2022-23 has been another year of transition for the health and care bodies and higher education institutions that form Health Innovation Wessex.

Responding to and recovering from the Covid-19 pandemic has put pressure on primary, secondary, community and social care services, and has affected parts of our innovation and research ecosystem in different ways. With these pressures likely to continue into the future, innovation remains vital for supporting the health service to tackle its most pressing issues.

Alongside improving population health and patient care, innovation will help us to address health inequalities, reduce workforce pressures, deliver a net zero NHS by 2040, and provide value for money for the taxpayer.

In 2022-23, we have continued to work with our partners to improve health outcomes and support economic growth by transforming the way that the NHS identifies, adopts and spreads promising and proven innovations.

This includes securing £2.88m of external funding for innovators, and supporting more than 250 organisations to develop innovation solutions to health and care challenges.

You can view our impact in numbers below.

Our impact in Wessex*:


jobs were created and/or safeguarded


hours saved through using eRD (electronic repeat dispensing)


economic growth for 260 companies through sales, investments and grants


views of our RESTORE2 and pulse oximetry videos


of eligible eating disorder services have adopted FREED to promote early assessment of eating disorders^


children benefited from using QbTest to support diagnostic decisions for ADHD^


practices have fully implemented Blood Pressure Optimisation Framework


people supported with a correct diagnosis of asthma through successful implementation of FeNO testing in primary care^


organisations were supported to find or develop innovation solutions

*2022-23 figures ^- estimated from project data

Over the last year, we have also remodelled our core team of clinical and non-clinical experts to create two delivery teams which will support our Integrated Care Systems (ICSs) in Dorset and Hampshire and Isle of Wight (HIOW) with their key aims for health and care moving forward.

This has involved working closely with our Integrated Care Boards (ICBs) to co-design delivery plans aligned to their local priorities, matching innovation to population health needs.

2023 has also been a year of milestones. As well as marking the 75th year of the NHS, the AHSN Network celebrated ten years of AHSNs and our role in ensuring that innovations, improvements and best practice within health and care benefit more people faster.

In the last year, we have contributed significantly to the national impact of the AHSN Network, with its latest report recognising the role of Health Innovation Wessex and its health and care partners in improving health, achieving excellence and boosting innovation in our region’s life sciences and healthcare sectors.

Since 2018, AHSN Network initiatives have benefited more than 2.3 million patients, with our support to innovators contributing more than £1.8bn to the UK economy, creating or safeguarding more than 6,600 jobs, and delivering a return on investment of almost £3 for every pound.

You can view our collective impact in numbers below.

AHSN Network impact in 2022-23:

More than


patients have benefited from our national programmes and initiatives

More than


innovations in our national pipeline of innovation



of investment leveraged by companies supported by AHSNs

Hear from our Chief Executive Officer, Bill Gillespie, who shares his highlights and reflections from the past year, and looks ahead to 2023-24, describing how we will continue to work with our system partners to improve health and care outcomes for the Wessex population.

About our 2022-23 Annual Review

In this review, we share our key impacts for 2022-23, as well as important learnings and outputs from our national and local programmes of work. This includes links to resources such as videos and podcasts, developed with our partners to drive the adoption and spread of innovation for a healthier Wessex.

The programmes we have delivered are either national commissions from NHS England (including supporting the Accelerated Access Collaborative and the Patient Safety Collaborative programme), and the Office for Life Sciences (OLS), or were created locally to respond to the needs of our system partners in Wessex.

Our review also outlines 2022-23 activities aligned to the strategic cross-cutting priorities which underpin all of our programmes of work. These include increasing digital capability, understanding and addressing health inequalities, meeting environmental sustainability targets, and implementing the AHSN Network’s commitments to equality, diversity and inclusion.

Scroll down to read the review in full or click the headers above to find out more about a specific programme or workstream.

Going digital

Digital innovation is integral to most activities in health and care, and all Health Innovation Wessex programmes include digital aspects within their workstreams.

In 2022-23, we have continued to support our local health and care systems with delivery of the digital-first offer outlined in the NHS Long Term Plan.

Our projects have focused on helping innovators to navigate the digital ecosystem, using digital technologies to improve patient care and deliver more flexible and equitable health and care services, as well as harnessing digital capability to establish new ways of working and improve workforce wellbeing.

In the last year, we created and launched our Digital Resources Hub which supports innovators, researchers, health and care staff, and AHSN teams on their innovation journey, from concept ideation through to funding and implementation.

Whether you’re looking to understand national guidance on digital health technology, or discover training opportunities for you or your team, our Digital Resources Hub provides a central repository which is easy to access and navigate. Watch our short video to find out how to navigate the Digital Resources Hub; we'll take you through the main sections.

Our Insight team also collaborated with Hampshire Hospitals NHS Foundation Trust (HHFT) to deliver a rapid evaluation of their virtual ward programme. The evaluation, which was funded by NHS England, provided timely information about the implementation and impact of virtual wards at a time when trusts across England were beginning to adopt this new approach to care. Our evaluation showed that the programme was safe and provided efficiencies, including value and benefits to patients, their carers and the virtual ward workforce.

Additionally, our Insight team supported delivery of the NHS Insights Prioritisation Programme (NIPP), funded by NHS England’s Accelerated Access Collaborative (AAC). This enabled us to partner with the National Institute for Health and Care Research (NIHR) Applied Research Collaboration Wessex (ARC) to accelerate the evaluation and implementation of digital interventions to support the care of people living with frailty.

To deliver this programme, we worked collaboratively with stakeholders from across the Integrated Care Systems (ICS) in Dorset and Hampshire and Isle of Wight (HIOW) to identify system priorities in this area. We also hosted two listening events with 40 members of the public to understand the views and perceptions of digital remote monitoring amongst older people with lived experience of frailty.

In the last year, we have also continued to explore how digital technologies can support patient care and new ways of working in primary care. This included working alongside Assura plc to deliver on our multi-year commission from HIOW Integrated Care Board (ICB) to research and evaluate innovations that could be placed within the Health Hub, a dedicated space which will be part of the new St Clements Partnership General Practice building. Construction for the new surgery in Winchester began in March 2023, following approval from Winchester City Council and HIOW ICB.

Going digital

“New buildings do not magically improve healthcare but they do give us the chance to reflect and reimagine care in a post pandemic world. This is why the Health Innovation Wessex multi-year study looking at new ways of working is so important. Through the study we aim to improve patient care and staff wellbeing while maximising flexibility and minimising health and digital inequalities.”

GP Partner
St Clements Partnership


Funded by the Government’s Office for Life Sciences (OLS), our industry team helps health and care innovators to realise the potential of their ideas.

As part of our wide range of structured and systematic support, we continue to deliver the Innovation Exchange to identify, select and encourage the adoption of innovations with the potential for health transformation, and to strengthen economic growth in the Wessex region.

Our offer is tailored to the needs and development stage of each innovation, complementing regional and national system priorities.

During 2022-23, we connected innovators with health and care staff facing specific challenges, providing support to over 260 companies. Of this number, over 100 innovators have each received more than five hours of support.

In collaboration with our colleagues at North East and North Cumbria (NENC) AHSN, we led on the delivery of the new NHS Innovation Service from NHS England’s Accelerated Access Collaborative (AAC). The initiative provides a central point of access to coordinated support and guidance from organisations with expertise in the development and widespread adoption of health innovation, and helps innovators get their innovation to clinicians and patients faster.

Health Innovation Wessex economic growth 2022-23:


companies supported


economic growth for the 260 companies through sales, investments and grants


jobs created or safeguarded


additional investment into system

“The dedication and expertise demonstrated by the AHSN team have been remarkable. Your contributions have helped us navigate through various challenges and achieve significant milestones. Your commitment to our projects has not gone unnoticed, and we deeply appreciate the support you have provided.”

MedTech founder

Innovation spread

Innovation supports our local health and care services to improve population health, provide equitable care, alleviate operational pressures, and offer value to the taxpayer.

In 2022-23, our Nationally Prioritised Innovations programme has continued to roll out high impact innovations to achieve improvements in care and outcomes, via both the NHS Innovation Accelerator (NIA) programme and NHS England’s Accelerated Access Collaborative (AAC) workstreams - the Rapid Uptake Products (RUP) programme and the MedTech Funding Mandate (MTFM).

For example, our national Fractional exhaled Nitric Oxide (FeNO) implementation programme, commissioned by the NHS England AAC, has continued to transform asthma care for patients in Wessex, and nationally, over the last year.

As lead AHSN, we have supported the further rollout of FeNO, a simple and non-invasive test which can be used to help diagnose and manage asthma, in primary care sites across all AHSN regions in England, supporting patients with confirmed or suspected asthma to access diagnostics and treatments in a timely manner.

FeNO testing can improve diagnosis for people with suspected asthma by providing clinical teams with an objective test result to consider as part of their decision making process. FeNO can also support people with confirmed asthma to manage their condition more effectively by enabling clinical teams to optimise a person’s medication and reduce the impact of asthma on their everyday lives.

As a result of the programme, we estimate that more than 58,000 patients across England been supported with the correct diagnosis more accurately and faster, including more than 3,700 in Wessex.

Additionally, in 2022-23 we have continued delivery of Asthma Biologics, a RUP programme which aims to improve patient care and reduce inequalities by increasing uptake of biological therapies for people with severe asthma. By providing bespoke support to health and care partners across Wessex, we were able to increase the number of patients accessing biologic therapy and reduce waiting times.

FeNO programme impacts


patients across England


patients in Wessex

supported with the correct asthma diagnosis more accurately and faster

Innovation spread

“FeNO has improved the safety of my patients and sped up the identification of diagnosis, phenotype and getting my patients on the right medication for them.”

Respiratory Nurse Specialist

“This project came at a time in my life where I felt powerless and lost on my asthma journey. Being a part of this group has given me the confidence to speak up for myself and to believe that I know my own body. I have learned so much and all of you have played a part in this. Thank you all for listening to me and trusting me.”

Patient representative


Our insight and evaluation experts support innovators and organisations to generate and use insights about the real-world impacts of innovations, improving system capability and capacity for adoption and spread, and bringing benefits for staff and patients.

During 2022-23, the work of our Insight team has included evaluations commissioned by our members and other organisations, regional commissions from NHS England, and real-world validations of early-stage innovations.

In the last year, we have produced six independent evaluation reports, which were published and shared with commissioners, and had 78 interactions with innovators, equating to more than 2,300 hours of support.

Additionally, we hosted ten new monthly Insight Evaluation Surgeries, offering regular opportunities for innovators to consult with experts in the team.

Over the last year, we have reported key findings and made recommendations for commissioners and providers on three primary care digital demonstrators, long Covid services, virtual wards, and cultural intelligence and inclusivity training.

We also continued a joint programme of work with the NIHR Applied Research Collaboration (ARC) Wessex to deliver the NHS Insights Prioritisation Programme (NIPP), which seeks to understand the impact of innovations for the digital remote monitoring of deterioration, particularly in people living with frailty.

As evaluation partner to Dorset Innovation Hub, we provided workshops for staff on evaluation and implementation and collected data to understand its impact, including a baseline survey of attitudes to innovation (Health Innovation Wessex ATIS survey) for reporting in 2023-24.

Over the last year, we have helped organisations to implement a learning health system approach, enabling us to drive improvement and generate lessons for the adoption and spread of innovations by the NHS.


hours of support


interactions with innovators

“A true piece of collaborative working enabling a final evaluation report for NHS England that we are all proud of.”

Associate Director for Clinical Strategy and Integration
Hampshire Hospitals NHS Foundation Trust

“We found the report extremely insightful and useful, and it will help us to steer continuous service improvement. In terms of client management, we couldn’t have asked for anything more from the Health Innovation Wessex team.”

Transformation Leads
Hampshire and Isle of Wight

Learning systems

Strong system working and highly adaptive approaches across organisations, provider collaboratives, Integrated Care Systems (ICSs), and research structures allow us to respond to local health and care needs, improve health outcomes, and support economic growth.

In 2022-23, we continued to support the creation of learning health systems through our wide experience and expertise in understanding and interpreting data, evaluating impact, and gathering insights from patients, staff and the public to enable rapid and innovative change.

Our ongoing work has supported learning health and care systems, as well as learning research and innovation ecosystems, to improve discovery, sustain development, and accelerate deployment through improvements to culture, processes and capabilities.

Over the last year, we have continued to drive the adoption and spread of innovation for a healthier Wessex, supporting development of the Dorset Innovation Hub and the Wessex Secure Data Environment.

Alongside this, we helped Wessex Health Partners move into its next phase of development, with the appointment of its Chair, Professor William Rosenberg, and its Managing Director, Christine McGrath.

“Wessex Health Partners brings together diverse partners from a range of academic disciplines across our universities, and from all parts of the health and care system across Wessex – from supporting wellbeing and enhancing our work to prevent ill health, to innovation in physical and mental health services, to the latest advances in genomics. William’s experience of and personal commitment to facilitating complex partnerships is an excellent fit with our Partners’ vision of building a learning health and care system.”

Dr Paul Johnson
Chief Medical Officer for Dorset NHS Integrated
Care Board

Wessex Health Partners logo

Cardiovascular disease

Cardiovascular disease (CVD) is a term used to describe a range of conditions affecting the heart or blood vessels. It accounts for a quarter of all deaths in the UK each year, and costs health services billions of pounds.

CVD is also the largest cause of premature death in deprived areas, and is a major contributor to the excess mortality that has occurred since the Covid-19 pandemic.

In its Long Term Plan, the NHS identifies reducing the incidence of CVD as the biggest area where it can save lives over the next ten years.

Our CVD programme improves patient care and health outcomes for the Wessex population by supporting our local health and care systems with the early detection, prevention and management of CVD and associated cardiovascular events.

By optimising treatments and innovations, we can better support those living with CVD to self-manage the condition, as well as prevent 150,000 strokes, heart attacks and cases of dementia in the next decade.

In 2022-23, work with our health and care partners has centred on the identification and management of patients with hypertension, familial hypercholesterolaemia and CVD.

As well as facilitating the adoption, spread and evaluation of innovations and novel therapies, we have focused on developing the knowledge and skills of health and care staff across Wessex, which has included the delivery of educational events and the production of training resources and materials.

“We do really value the Health Innovation Wessex team’s input and hope to continue working with you on CVD into the future.”

GP specialising in CVD and public health

Healthy ageing

Our healthy ageing programme builds on the strengths of existing Health Innovation Wessex programmes to provide a cross-cutting approach to healthy ageing and frailty.

We add value to the frailty agenda and innovation activities in Wessex, retaining focus on the spread and adoption of innovation across the region.

With our shared commitment to both slow the onset and reduce the severity of frailty, we work with partners to develop and disseminate tools and approaches for improving patient care.

In 2022-23, we progressed collaborations with our local partners, as well as those in our regional and national health and care systems, continuing to identify and promote best practice through our audit work and improvement projects.

For example, we worked in partnership with two NHS Trusts, Hampshire Hospitals and South Central Ambulance Service, to review the innovative north Hampshire falls and frailty car service, and consolidate learning into an Urgent Community Response Frailty Service Toolkit, which can support the spread of the model across England and help ambulance services to deliver the national urgent community response target.

The falls and frailty car service and toolkit were subsequently nominated for two prestigious Health Services Journal (HSJ) awards, and adopted by the Skills for Health Urgent Community Response Capabilities Framework.

We also worked with our expert frailty clinical leads and representatives from our Integrated Care Boards (ICBs) to co-design and develop our novel Wessex frailty virtual ward translator tool, which aims to support system partners to optimise their frailty virtual ward delivery offer.

Additionally, we published the findings from our 2022 Health Innovation Wessex Proactive Care audit, which was produced in collaboration with the ICBs for Dorset and Hampshire and Isle of Wight. The audit, which consists of 58 responses from ICB colleagues and representatives from other health and care organisations, highlights innovative best practice and opportunities within proactive care provision to support ICBs with future planning.

We have continued to work with local systems and innovators to identify areas of opportunity to support individuals living with frailty. This includes supporting the NHS Insights Prioritisation Programme (NIPP) in evaluation of the use, applicability, and acceptability of digital remote monitoring for individuals living with frailty within the community. Working with our academic partners, we organised six community engagement listening events across Wessex in 2022-23, allowing us to gather feedback from those with lived experience.

Healthy ageing

“Health Innovation Wessex's reputation has opened up doors for us with our executive team, alongside garnering energy for local education events.

It has provided us with great kudos being associated with the organisation and the programme and has enabled us to influence, with authority.

The development of a Comprehensive Geriatric Assessment toolkit has acted as a lever to hang our operational framework on, supporting service and workforce redesign.”

Team Leader
NHS Trust


Medicines optimisation supports people to get the medication they need, when they need it. It helps to ensure that the medicines we use offer value, both in terms of clinical and cost effectiveness.

In 2022-23, our medicines optimisation programme has continued to support patients across Wessex to get the most from their medicines, reducing problematic polypharmacy and improving the processes around repeat prescribing.

Through its core principles of population health management, public behaviour change, and education and training, our polypharmacy programme aims to improve patient outcomes and medicines safety.

In 2022-23, we continued to focus on supporting people to take their medicines correctly, alongside helping to avoid patients taking medication unnecessarily and addressing the wastage that this causes.

Through ongoing collaboration with our local health and care systems, our programme continues to support our workforce to identify at risk patients and prioritise them for a structured medication review.

Electronic Repeat Dispensing (eRD) is a way of dispensing prescriptions electronically. It can benefit patients who take the same medication regularly by enabling their prescription to be sent straight to their pharmacy, meaning they do not need to visit their GP every time.

eRD also has benefits for our health and care system, reducing workload for prescribers and enabling better management of the medicines supply chain.

Despite this, we identified key barriers to eRD in Wessex, including limited understanding of the benefits, a lack of national resources to support successful setups, and no champions to drive the change.

Our eRD programme was set up to address this, and delivery continued throughout 2022-23. This includes the provision of regular training (action learning sets) for our health and care workforce, alongside chairing the Wessex eRD steering group, which meets four times a year.

In 2022-23, the programme has helped release over 7,000 GP hours in Wessex.


GP hours released

“Due to many problems with the buses, plus difficulties obtaining doctors' appointments, I find it helpful. Plus, I find it saves my GP work […] thus saving the delivery service time, effort and expense, hopefully helping the NHS, too.”

Patient using eRD in Wessex

“As a GP partner with a significant number of elderly and vulnerable patients under my care, I found the action learning sets invaluable for building confidence in working with patients to tackle polypharmacy. This includes the provision of patient support aids and approaching difficult ‘de-prescribing’ conversations with more structure and clearer objectives.

The action learning sets were also a fantastic opportunity to understand the challenges and solutions across multiple professional domains.

I thoroughly recommend the learning sets for any professional who has the headspace and enthusiasm to improve polypharmacy.”

GP Partner at St Clements Surgery, Winchester

Mental health

Our mental health programme brings together expertise from commissioners, clinicians, service users, families, and local communities to improve the lives of those affected by mental health conditions.

Working collaboratively with innovators and partners across our health and care system, we support the spread and adoption of innovation within mental health, speeding up the sharing of good practice.

In 2022-23, we have continued to support and deliver the national programmes for eating disorders and neurodevelopmental services, identifying variation in mental health outcomes and helping our health and care systems to harness innovation to address challenges.

This includes delivery of Focus ADHD, a programme which supports our NHS mental health trusts and community paediatric services to improve the assessment and diagnosis of attention deficit hyperactivity disorder (ADHD) for children and young people.

The programme aims to increase the number of children and young people who have an objective assessment (QbTest) as part of the clinical pathway, standardising practice and providing a clearer, unbiased clinical picture.

Since it began in April 2020, it has benefited over 55,000 patients, and has also led to a 19% release of clinical time in paediatrics, as well as 9.2% in Child and Adolescent Mental Health Service (CAMHS).

During 2022-23, we also continued to deliver FREED, a programme which supports mental health teams to accelerate the diagnosis and treatment of eating disorders in young people using an innovative model designed to enable rapid access to specialised support.

The programme has benefited almost 300 patients in the south east and Dorset since it began, and is being delivered at eight mental health trusts across the Wessex, Oxford and Kent Surrey Sussex AHSN footprints.


patients benefitted from the Focus ADHD programme^


release of clinal time in paediatrics as a result of implementing Focus ADHD^


patients in south east and Dorset received specialist support as part of the FREED programme^

“I would say that going to treatment actually saved my life, really. I was told by my doctor I wouldn’t make it through my twenties if I carried on in the way that I was acting, so I think that early intervention in eating disorders is so crucial. You don’t want to waste your life… you do deserve to get better.”

FREED service user
Sussex Eating Disorder Service

FREED logo

Patient safety

The Patient Safety Collaborative (PSC) is hosted by Health Innovation Wessex and commissioned by NHS England’s National Patient Safety Team to deliver a number of Safety Improvement Programmes (SIPs).

Over the last year, we have continued to use our experience and expertise to support partners across our health and care system. We have worked collaboratively to improve patient safety and achieve the objectives set out in the NHS Patient Safety Strategy, building on the foundations of a safer culture and safer systems.

In 2022-23, we focused on five priority SIPs (systems; managing deterioration; medicines; mental health and maternity and neonatal) and developed and matured our Patient Safety Networks as the main route for delivering these programmes.

Over the course of the year, we held 16 events and webinars with a total of 553 attendees, bringing together NHS providers, commissioners, patients and health and care staff to share learning, best practice and enable system-wide safety improvements.

Within our managing deterioration SIP, we supported our systems to sustain deterioration management tools in 481 (54%) care homes in Wessex. We also achieved over 1.2 million views of the suite of videos which support RESTORE2, a physical deterioration and escalation tool for nursing and care homes. The tool was co-produced and co-designed by the Wessex Patient Safety Collaborative and West Hampshire Clinical Commissioning Group (now part of Hampshire and Isle of Wight Integrated Care Board).

Within medicines safety, we delivered the first year of our workplan, which included the development and completion of the Opioid Prescribing Comparators Dashboard in collaboration with the NHS Business Services Authority (NHSBSA). The dashboard aims to support general practices and Primary Care Networks (PCNs) with understanding their opioid prescribing and identifying patients at risk of harm. Additionally, we produced three podcasts with our health and care experts to showcase local improvement initiatives that have contributed to reducing opioid prescriptions.


events and webinars




views of our RESTORE2 video suite

“The help of the PSC is invaluable. You are absolutely part of our journey, driving us forward and providing that challenge and insight from a wider perspective.”

Head of Risk Management, NHS Trust

Primary and community care

In 2022-23, we worked collaboratively with local clinicians and the wider primary and community care workforce, hosting listening events and workshops to understand the local need and make recommendations for innovations which could bring benefits to patients and the system, both now and in the future.

We continued our partnership with our Integrated Care Systems (ICSs) and Integrated Care Boards (ICBs) in Dorset and Hampshire and Isle of Wight (HIOW), identifying challenges facing the wider primary and community care community and ways to address them.

This involved prioritising areas of need and opportunity, as well as supporting the adoption and spread of new and proven innovations and new ways of working to fundamentally improve patient outcomes and the efficiency of clinical services.

2022-23 saw the completion of the Self-Care Demonstrator Site Project, which allows general practices and Primary Care Networks (PCNs) to trial emerging technologies or market-ready innovations without making a long-term commitment. These structured short-term pilots also benefited innovators, helping them to test their products in a real-world clinical setting and generate insights into usability to inform future development.

Driving digital transformation within primary and community care was a key focus for 2022-23. In January 2023, we supported health innovation company, xim Limited, and HIOW ICS to provide a blood pressure checking service at a shopping centre in Basingstoke for members of the public receiving their Covid-19 booster vaccine. The service used a new technology called Lifelight to identify people with high blood pressure (hypertension), who were then advised to contact their GP. Lifelight works by allowing smartphone or tablet devices to measure blood pressure, pulse and breathing rate simply by looking into the device’s built-in camera for 40 seconds.

We also continued to work alongside Assura plc to deliver on our multi-year commission from HIOW ICB to research and evaluate innovations that could be placed within the Health Hub, a dedicated space which will be part of the new St Clements Partnership general practice building in Winchester. Construction for the new surgery began in March 2023, following approval from Winchester City Council and HIOW ICB.

“We are delighted to see St Clements Surgery break ground and move forward with their new premises. This project has been a great example of collaborative working between practice staff, primary care, system commissioners, specialist developers, the local authority and public stakeholders. Health Innovation Wessex is proud to have supported the practice to identify innovative ways of working to encourage the wellbeing of staff and improve the experience for patients.”

Nicola Bent
Deputy Chief Executive Officer, Health Innovation Wessex

“The ability for our patients to have their blood pressure and other vitals checked at the same time as receiving their Covid or flu vaccine just makes sense for both patient and the NHS. We’re finding patients who had no idea they had hypertension getting picked up by Lifelight, allowing us to intervene so they can receive the right care to manage their condition. Too many patients unfortunately only realise they have high blood pressure when they find themselves in hospital with a heart attack or stroke.”

Transformation Leads
Hampshire and Isle of Wight

Strategic activities

We bring together the NHS, industry, academia, the third sector and local organisations to support the spread and adoption of innovations which improve health and achieve economic growth.

Strategic partnerships and business development

By working collaboratively with health and care partners, we maximise the impact we have for our stakeholders, and help bring benefits to patients faster.

This year, we have continued to seek and establish new strategic partnerships, whilst strengthening and growing existing ones. This includes Health Innovation Wessex’s role as joint chair of the formal partnership with the National Institute for Health and Care Excellence (NICE), as well as collaborations with the NIHR Applied Research Collaboration (ARC) Wessex and the NHS Digital Academy.

This will support us to develop and implement a coherent and ambitious strategy for business and new product development in the coming year, enabling us to diversify and expand income sources.

Strategic activities

Health inequalities and Public Partnerships and Community Conversations (PPCC)

We are committed to addressing the inequalities which exist within our local and national health and care systems. This includes improving access to health care environments and treatment pathways, as well as reducing barriers to technology which can result in digital exclusion.

Throughout 2022-23, we have continued to take a strategic approach to our health inequalities work, embedding the core principles of equality, diversity and inclusion as a cross-cutting theme across all of our programmes.

Key areas of focus have included digital equity, population health management and understanding regional disparities. We have also set clear objectives to educate and support innovators to develop and evaluate innovations that are accessible, sustainable and affordable for all.

Our health inequalities work has been developed and shaped in collaboration with our patient and public partners, who have supported our conversations with local communities.

Environmental sustainability and net zero

In October 2020, the NHS became the world’s first health service to pledge to reach carbon net zero in response to the profound and growing threat to health posed by climate change.

Locally, we remain committed to supporting our local health and care systems with innovation which promotes sustainability across the entire lifecycle, from the supply chain through to improved patient outcomes.

Throughout 2022-23, delivery plans for our national and local programmes were underpinned by, and reported on, our progress in meeting net zero ambitions.

We have also focused our time on establishing relationships and forging links with regional and local environmental sustainability leads, to gain an understanding of their priorities and support their future delivery.

Strategic activities

“Clean air is a fundamental requirement for a healthy and sustainable life. The air we breathe directly affects our respiratory system, cardiovascular health, and overall wellbeing. However, in many parts of the world, air pollution has reached alarming levels due to industrial emissions, vehicle exhaust, burning of fossil fuels, and other human activities.”

Health Innovation Wessex Environmental Sustainability team

Our members

We are a member-led organisation, with collaboration at the heart of all we do. Engagement with the NHS system, local authorities, enterprise partnerships, universities, industry and the third sector, both in co-production and direct investment, is central to our work.